Wearable Ultrasounds Poised to Revolutionize Healing and Pain Management Healthcare Market
The result, Sustained Acoustic Medicine (sam), was found to be capable of altering the trajectory of soft tissue cells to stimulate remodeling and healing.
- The result, Sustained Acoustic Medicine (sam), was found to be capable of altering the trajectory of soft tissue cells to stimulate remodeling and healing.
- Initially commercialized for the veterinary market in 2010, the company's productULTROZwas used to heal soft tissue injuries in dogs and horses.
- By 2014, ZetrOZ had pivoted to exclusively serve the human market, building on an existing low-intensity pulsed ultrasound medical technology called Exogen.
- Their flagship product, sam, is an in-home, ultrasound treatment that reduces the need for pain medication and surgery.